Tumor angiogenesis is driven primarily by hypoxia; in hypoxic conditions, cancer cells secrete VEGFA, which engages the VEGFR2 receptor on nearby vascular endothelial cells, stimulating the growth of new vascular sprouts [36] (Figure 1B). The gene discussed is VEGFA; the disease is neoplasm.